Profile of federal purchases of insulins in Brazil: the impact of biosimilars entry. Research, Society and Development, [S. l.], v. 11, n. 4, p. e1511427073, 2022. DOI: 10.33448/rsd-v11i4.27073. Disponível em: https://rsdjournal.org/rsd/article/view/27073. Acesso em: 5 dec. 2025.